LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Tianlong Demonstrates Latest Biochemistry, Immunology, POCT and Molecular Diagnostic Products

By LabMedica International staff writers
Posted on 12 Nov 2024
Image: The Panall 8000 All-in-one Molecular Diagnosis system (Open system) is on display at MEDICA 2024 (Photo courtesy of Tianlong)
Image: The Panall 8000 All-in-one Molecular Diagnosis system (Open system) is on display at MEDICA 2024 (Photo courtesy of Tianlong)

Tianlong Science and Technology (Shaanxi, China) is participating in the MEDICA 2024 exhibition where the company is showcasing its cutting-edge diagnostic solutions and latest products in biochemistry, immunology, POCT, and molecular diagnostics.

Among Tianlong’s innovations featuring at this year’s MEDICA is the Panall 8000 All-in-one Molecular Diagnosis system (Open system) that enables laboratories to program user-defined PCR analysis protocols. Laboratories can use user-defined protocols in addition to those developed by Tianlong. The simple and efficient design of the Panall 8000 allows labs to test a wide range of sample types and meet emerging diagnostic requirements through customized reagents. Tianlong intends to bring more new tests to the Panall 8000 for detection of a broad range of disease categories.

Also featuring at MEDICA 2024 is the Gentier X3 Series Real-Time PCR System that features three independent thermal blocks, supporting users to run a maximum 3×32 well samples in three different protocols simultaneously. This can help labs save a lot of time and budget. With the powerful and efficient temperature control system, user-friendly operational designs, Tianlong Gentier X3 Series can provide maximal reliability and efficiency for all real-time PCR needs. Tianlong is also highlighting the Biolum Portable ATP Hygiene Monitoring System Pro which features an innovative design, making it a smartphone in the user’s hand. Featuring state-of-the-art technology, the new device can provide rapid and accurate data to support hygiene monitoring programs. Cloud-based data management enables users to monitor, track, and trend testing results across multiple facilities, making risk management easier than ever.

Additionally, Tianlong is presenting the V150 automatic chemiluminescence immunoassay analyzer designed for small and medium-sized laboratories, while also offering the capability for emergency testing in large hospitals and third-party laboratories. Alongside, Tianlong is highlighting the ZY-260 automatic clinical chemistry analyzer that uses concave grating photometry post-spectroscopic technology and has a constant speed of 200 tests/hour. The ZY-260 also features an AAA-supported system with improved traceability for ensuring the accuracy of results and has a high-capacity sample tray and reagent tray, allowing 72 clinical chemistry items to be run simultaneously.

Related Links:
Tianlong Science and Technology

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
8-Channel Pipette
SAPPHIRE 20–300 µL

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more